ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 978,51
0,55%
Dow Jones
38 111,48
-0,86%
DAX
18 496,79
0,12%
Brent Oil
81,95
-1,71%
Bitcoin
68 298,33
1,06%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Accelerated Pharma (MM) (ACCP)

  7. Accelerated Pharma (MM) (ACCP) Actualités

ACCP

ACCELERATED PHARMA, INC. (ACCP)

Accelerated Pharma (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACCP
DateHeureSourceTitreSymboleSociété
22/04/202018h45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACCPAccelerated Pharma (MM)
06/02/202015h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACCPAccelerated Pharma (MM)
05/02/202017h33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACCPAccelerated Pharma (MM)
08/11/201912h00Edgar (US Regulatory)Effectiveness Order (effect)NASDAQ:ACCPAccelerated Pharma (MM)
06/11/201912h06Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
22/10/201812h06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ACCPAccelerated Pharma (MM)
23/08/201718h10Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ACCPAccelerated Pharma (MM)
18/04/201720h22Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ACCPAccelerated Pharma (MM)
04/02/201015h00PR Newswire (US)Access Pharmaceuticals Initiates Program Applying Cobalamin Platform to siRNA Drug DeliveryNASDAQ:ACCP
02/02/201021h22PR Newswire (US)Access Pharmaceuticals Announces Closing of $6.3 Million in Registered Direct OfferingNASDAQ:ACCP
22/01/201015h29PR Newswire (US)Access Pharmaceuticals Raises $6.3 Million In Registered Direct OfferingNASDAQ:ACCP
19/01/201015h00PR Newswire (US)Access Pharmaceutical's Cobalamin Oral Insulin Achieves Greater Than 80% Oral Bioavailability In Preclinical ModelsNASDAQ:ACCP
07/01/201014h30PR Newswire (US)Access Pharmaceuticals Announces Completion of ProLindac Monotherapy Trial and Initiation of Combination StudyNASDAQ:ACCP
06/01/201015h00PR Newswire (US)Access Pharmaceuticals To Present at OneMedPlace Forum 2010NASDAQ:ACCP
15/12/200915h00PR Newswire (US)Access Pharmaceuticals Appoints Sales and Marketing ExecutiveNASDAQ:ACCP
03/12/200918h48PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in EuropeNASDAQ:ACCP
17/11/200915h00PR Newswire (US)ChangeWave Issues Buy Recommendation on Access PharmaceuticalsNASDAQ:ACCP
11/11/200915h00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North AmericaNASDAQ:ACCP
15/10/200914h00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians FeedbackNASDAQ:ACCP
06/10/200914h00PR Newswire (US)Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)NASDAQ:ACCP
11/09/200915h00PR Newswire (US)Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United StatesNASDAQ:ACCP
10/09/200915h00PR Newswire (US)Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development PlanNASDAQ:ACCP
01/09/200915h00PR Newswire (US)Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare ConferenceNASDAQ:ACCP
03/08/200912h00PR Newswire (US)Access Pharmaceuticals Provides Update on ProLindac Clinical Development ProgramNASDAQ:ACCP
29/07/200915h00PR Newswire (US)Access Pharmaceuticals Announces New MuGard Commercial Strategy in North AmericaNASDAQ:ACCP
27/07/200915h00PR Newswire (US)Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharmNASDAQ:ACCP
23/07/200915h00PR Newswire (US)MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer PatientsNASDAQ:ACCP
22/07/200917h08PR Newswire (US)UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock ConferenceNASDAQ:ACCP
22/07/200915h00PR Newswire (US)Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock ConferenceNASDAQ:ACCP
13/07/200914h30PR Newswire (US)Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales ConfeNASDAQ:ACCP
 Showing the most relevant articles for your search:NASDAQ:ACCP

Dernières Valeurs Consultées

TG
C1Z
Century Lithium
LSE
89KK
Int.fin. 26
LSE
44LD
Int.fin. 26
EU
INBXX
Sgam Bxx Inav
EU
JPCLG
Euronext JPN Screened Cl...
TG
4G9
GBLT
NYSE
AFTR
AfterNext HealthTech Acq...
USOTC
RADCQ
Rite Aid (CE)
NASDAQ
FLXS
Flexsteel Industries
NASDAQI
XAI
EXANTE Altcoin Cryptocur...
BOV
ELETG280
ELETG280 Ex:27,6
COIN
OCBBTC
Ocbtoken - Blockmax
LSE
31ZW
Int.fin. 26
LSE
71DW
Investec Bnk 23
COIN
AMPLUST
Ampleforth
BIT
F12478
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés